Representatives of the United States and the eleven other parties to the Trans-Pacific Partnership agreed on groundbreaking protections for intellectual-property rights in biological drugs. But the standards are uneven, the result of eleventh-hour negotiations whose details remain largely secret.
This article is a case study about the rules of origin (ROOs) dealing with products undergoing outward processing (OP) in the Kaesong Industrial Complex (KIC). OP refers to temporary exportation of goods for further manufacturing. As the word “temporary” indicates, the finished goods are usually imported back to the home country for domestic consumption or permanent exportation.